Urinary symptoms: broadening the horizons for the copeptin assay
- 9 Downloads
The authors thank Karel Everaert, Jason M. Lazar, Joseph G. Verbalis, and Jeffrey P. Weiss for their contributions to the content and critical revisions of this correspondence.
Monaghan, Bliwise, and Wein contributed to the content, drafting, and critical revisions of this correspondence.
Compliance with ethical standards
Conflicts of interest
Thomas Monaghan has nothing to disclose. Dr. Bliwise has served as a consultant for Merck, Jazz, Ferring, Eisai, and Respicardia and speaker for Merck within the last three years, outside the submitted work. Dr. Wein has served as an advisor/consultant for Avadel, GTX, Acquinox, Urovant, Medtronic, and Serenity within the last three years, outside the submitted work.
This correspondence was written in accordance with the Ethical Standards outlined by the Journal of Endocrinological Investigation.
- 1.Christ-Crain M, Fenske WK (2019) Copeptin in the differential diagnosis of hypotonic polyuria. J Endocrinol Invest. https://doi.org/10.1007/s40618-019-01087-6 [Epub ahead of print]